All Cancer Microbiology articles – Page 3
-
NewsCancer drug could be repurposed to fight Covid-19
Twelve years ago, cancer researchers identified a molecule that helps cancer cells survive by shuttling damaging inflammatory cells into tumor tissue. In new research, they show that the same molecule does the same thing in lung tissue infected with COVID-19.
-
NewsChanging the gut microbiome boosts health outcomes for people newly diagnosed with metastatic kidney cancer
Researchers have developed a novel use of biotherapeutic product CBM588 in the treatment of cancer; new research suggests the agent adjusts people’s microbiome, possibly leading to enhanced effectiveness of FDA-approved cancer immunotherapies.
-
NewsBreakthrough research makes cancer-fighting viral agent more effective
Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.
-
NewsResearchers harness intratumoral microbiome against colorectal cancer
Scientists have established a microbiota-targeted drug delivery system that exhibits high efficiency in colorectal cancer targeting and colon retention.
-
NewsResearchers deploy E coli to selectively target tumor cells
Scientists explore how an engineered bacterium limits tumor growth and maximizes targeted anticancer drug delivery.
-
NewsChemotherapy disrupts gut microbiome in patients with breast cancer
Patients treated with chemotherapy who showed decreases in cognitive performance also had reductions in the diversity of their gut microbiome, a new study has found.
-
NewsOncolytic virus inhibits liver cancer growth by inducing cell cycle arrest and apoptosis
Researchers have found that administration of an oncolytic virus, Senecavirus A, effectively suppressed hepatocellular carcinoma proliferation and growth in a mouse model placed beneath the skin by triggering apoptosis.
-
NewsScientists map role of Porphyromonas gingivalis in chemotherapy resistance
A new paper describes how the bacterium Porphyromonas gingivalis interferes with chemotherapy-induced mitophagy, allowing oral cancer tumors to become resistant to the drug’s effects.
-
NewsResearchers advise strengthening immunity against COVID-19 in people with cancer
Researchers who led a study on the effectiveness of vaccines against COVID-19 among cancer patients in Catalonia, have recommended administering additional doses of the vaccine among this risk population.
-
NewsSafer virus helps eliminate cancer and protect against future tumors
Scientists have discovered that an attenuated (weakened) virus can help eliminate cancer in mice. In addition, mice that were treated with this virus were more resistant to developing tumors later in life.
-
NewsEpstein-Barr virus can trigger quicker growth of nasopharyngeal cancer
Scientists have shown how the Epstein-Barr virus (EBV) alters how specific genes are regulated, making nasopharyngeal cancer tumours (NPC) grow faster.
-
NewsLung microbiomes predict mortality in children following bone marrow transplant
Using a method that identifies all potentially pathogenic organisms present in the lungs, scientists have discovered links between certain microbial communities and the relative risk of mortality in children who undergo bone marrow transplants.
-
NewsAntibacterial protein offers new therapeutic target against pancreatic cancer
A recent study describes how pancreatic cancer stem cells take advantage of an antibacterial protein, PGLYRP1, to evade the immune system and protect themselves from early elimination.
-
NewsSpecific microbial hallmarks in vagina could indicate gynecological cancers
A new study demonstrates unique vaginal microbiome in patients with gynecological cancers which could function as a biomarker.
-
NewsNew viral strain induces immunogenic cell death in tumour cells
A study has developed a new strain of vaccinia virus, which can replicate in tumour cells while maintaining increased immunogenicity. Specifically, it can to induce so-called immunogenic cell death in tumour cells.
-
News'Failed drug' could offer new approach to Epstein-Barr virus and resulting diseases
Researchers have found that the Epstein-Barr virus triggers infected cells to ramp up the production of an enzyme known as IDO1, a discovery that offers a promising starting point for putting the brakes on EBV.
-
News HPV testing for cervical cancer may be safe at longer intervals than recommended by current guidelines
The risk of detecting cervical precancer eight years after a negative HPV screening was found to be similar to the risk after three years (the commonly recommended screening interval) after a negative cytology screening.
-
NewsGut bacteria boost immune response to fight tumors
Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer. Such an approach to beating cancer has seen significant success in lung cancer and melanoma, among others. Optimistic about its potential, researchers are exploring strategies to improve ...
-
NewsScientists make strides in microbiome-based cancer therapies by iron deprivation at the tumor microenvironment
Researchers have made a significant breakthrough in the fight against cancer, exploring a dietary-derived bacterial strain, IMB001, that induces ’nutritional immunity’ to boost anti-tumor responses.
-
NewsHPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK. Source: NIAID Colorized electron micrograph of HPV virus particles harvested and ...
